Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Di Marco

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Structure (London, England : 1993)|June 16, 1999
The 1.2 A crystal structure of hirustasin reveals the intrinsic flexibility of a family of highly disulphide-bridged inhibitorsI Usón, G M Sheldrick, E de La Fortelle, et al.
The Journal of Biological Chemistry|March 7, 1997
Structure of recombinant human CPP32 in complex with the tetrapeptide acetyl-Asp-Val-Ala-Asp fluoromethyl ketoneP R Mittl, S Di Marco, J F Krebs, et al.
Journal of Molecular Biology|October 21, 1994
Domains of interaction between alpha interferon and its receptor componentsG Uzé, S Di Marco, E Mouchel-Vielh, et al.
European Heart Journal|December 9, 2010
Cardioprotective effect of calcineurin inhibition in an animal model of renal diseaseGiovana S Di Marco, Stefan Reuter, Dominik Kentrup, et al.
Plos One|September 21, 2011
Circulating endothelial progenitor cells in kidney transplant patientsGiovana S Di Marco, Peter Rustemeyer, Marcus Brand, et al.
Cancer Gene Therapy|February 24, 2001
Antitumor activity of recombinant adenoviral vectors expressing murine IFN-alpha in mice injected with metastatic IFN-resistant tumor cellsL Santodonato, M Ferrantini, F Palombo, et al.
Kidney International|July 27, 2016
Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney diseaseSaurav Singh, Alexander Grabner, Christopher Yanucil, et al.
Basic Research in Cardiology|April 21, 2015
Soluble Flt-1 links microvascular disease with heart failure in CKDGiovana S Di Marco, Dominik Kentrup, Stefan Reuter, et al.
Kidney International|March 3, 2019
Increased soluble fms-like tyrosine kinase 1 after ischemia reperfusion contributes to adverse clinical outcomes following kidney transplantationTheresa M Wewers, Anna B Mayer, Alexander Pfleiderer, et al.
Biochemistry|April 23, 1999
Multiple determinants influence complex formation of the hepatitis C virus NS3 protease domain with its NS4A cofactor peptideA Urbani, G Biasiol, M Brunetti, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Structure (London, England : 1993)|June 16, 1999
The 1.2 A crystal structure of hirustasin reveals the intrinsic flexibility of a family of highly disulphide-bridged inhibitorsI Usón, G M Sheldrick, E de La Fortelle, et al.
The Journal of Biological Chemistry|March 7, 1997
Structure of recombinant human CPP32 in complex with the tetrapeptide acetyl-Asp-Val-Ala-Asp fluoromethyl ketoneP R Mittl, S Di Marco, J F Krebs, et al.
Journal of Molecular Biology|October 21, 1994
Domains of interaction between alpha interferon and its receptor componentsG Uzé, S Di Marco, E Mouchel-Vielh, et al.
European Heart Journal|December 9, 2010
Cardioprotective effect of calcineurin inhibition in an animal model of renal diseaseGiovana S Di Marco, Stefan Reuter, Dominik Kentrup, et al.
Plos One|September 21, 2011
Circulating endothelial progenitor cells in kidney transplant patientsGiovana S Di Marco, Peter Rustemeyer, Marcus Brand, et al.
Cancer Gene Therapy|February 24, 2001
Antitumor activity of recombinant adenoviral vectors expressing murine IFN-alpha in mice injected with metastatic IFN-resistant tumor cellsL Santodonato, M Ferrantini, F Palombo, et al.
Kidney International|July 27, 2016
Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney diseaseSaurav Singh, Alexander Grabner, Christopher Yanucil, et al.
Basic Research in Cardiology|April 21, 2015
Soluble Flt-1 links microvascular disease with heart failure in CKDGiovana S Di Marco, Dominik Kentrup, Stefan Reuter, et al.
Kidney International|March 3, 2019
Increased soluble fms-like tyrosine kinase 1 after ischemia reperfusion contributes to adverse clinical outcomes following kidney transplantationTheresa M Wewers, Anna B Mayer, Alexander Pfleiderer, et al.
Biochemistry|April 23, 1999
Multiple determinants influence complex formation of the hepatitis C virus NS3 protease domain with its NS4A cofactor peptideA Urbani, G Biasiol, M Brunetti, et al.
Pageof 6